Journal of Medicinal Chemistry · 2002 · 19 citations · 18 references
PharmacyMedicinal ChemistryPharmacologyBioisosterismDrug DesignMolecular VirologyAntiretroviral TherapyAntiviral AgentsAntiviral PharmacologyAntiviral TherapyBioisosteric DesignEnzyme InhibitionAntiviral Drug DesignAntiviral Structure-activity RelationshipsBioisosteric Lead ModificationChemical Synthesis Of AnaloguesHiv Antiretroviral TherapyMultistep SynthesisPyrimidine BioisosteresSulfur-containing Bioisosteres
Starting from the chemical structure of the recent FDA-approved anti-HIV drug Amprenavir (Agenerase), a potent HIV-protease inhibitor, we have designed new series of Amprenavir bioisoteres in which the methylene group of the benzyl group was replaced by a sulfur atom. This structural modification has required an original multistep synthesis. Unfortunately, introduction of the sulfur atom abolished or drastically decreased both inhibitory activity on recombinant HIV protease and HIV infection protection on MT4 cell cultures.
18
Nucleotide sequence of the AIDS virus, LAV
Simon Wain–Hobson, P. Sonigo, Olivier Danos et al. · Cell · 1985 · 1.2K citations
A structural model for the retroviral proteases
Laurence H. Pearl, William R. Taylor · Nature · 1987 · 599 citations